AutoCanada Inc.

TSX (CAD): AutoCanada Inc. (ACQ)

Last Price

18.90

Today's Change

+3.78 (25.00%)

Day's Change

15.99 - 19.05

Trading Volume

222,936

Overview

Market Cap

437 Million

Shares Outstanding

23 Million

Avg Volume

55,069

Avg Price (50 Days)

15.33

Avg Price (200 Days)

19.48

PE Ratio

-12.04

EPS

-1.57

Earnings Announcement

13-Nov-2024

Previous Close

15.12

Open

15.99

Day's Range

15.99 - 19.05

Year Range

13.75 - 27.44

Trading Volume

222,936

Price Change Highlight

1 Day Change

25.00%

5 Day Change

27.36%

1 Month Change

17.32%

3 Month Change

26.76%

6 Month Change

-10.43%

Ytd Change

-17.83%

1 Year Change

-2.33%

3 Year Change

-49.38%

5 Year Change

59.49%

10 Year Change

-65.20%

Max Change

80.00%

News and Blogs

No result.

Company Profile

Sector: Consumer Cyclical - Consumer Cyclical

Industry: Auto & Truck Dealerships

Description:

AutoCanada Inc., through its subsidiaries, operates franchised automobile dealerships. The company offers a range of automotive products and services, including new and used vehicles, vehicle leasing, vehicle parts, vehicle maintenance and collision repair services, extended service contracts, and vehicle protection and other after-market products. It also arranges financing and insurance for vehicle purchases by its customers through third-party finance and insurance sources. The company sells its vehicles under the Chrysler, Dodge, Jeep, Ram, FIAT, Alfa Romeo, Chevrolet, GMC, Buick, Cadillac, Ford, Infiniti, Nissan, Hyundai, Subaru, Audi, Volkswagen, Kia, Mazda, Mercedes-Benz, BMW, MINI, Volvo, Toyota, Lincoln, Porsche, and Honda brands. As of March 2, 2022, it operated 78 franchised dealerships in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nova Scotia, and New Brunswick in Canada, as well as in Illinois, the United States. The company also offers used vehicles online. AutoCanada Inc. was incorporated in 2009 and is headquartered in Edmonton, Canada.

Discussions
1 person likes this. Showing 0 of 0 comments

Post a Comment